Table 5.
Name | Formation |
Growth |
||||
---|---|---|---|---|---|---|
ΔfH⁰bio (kJ/C-mol) | S⁰m,bio (J/C-mol K) | ΔfG⁰bio (kJ/C-mol) | ΔrH⁰ (kJ/C-mol) | ΔrS⁰ (J/C-mol K) | ΔrG⁰ (kJ/C-mol) | |
SARS-CoV-2: Entire virus | -64.7 ± 30.5 | 30.7 ± 6.1 | -24.8 ± 32.3 | -4.8 ± 60.1 | 6.9 ± 13.2 | -6.9 ± 64.0 |
SARS-CoV-2: Nucleocapsid | -75.9 ± 29.4 | 32.5 ± 6.4 | -33.7 ± 31.3 | -233.4 ± 59.0 | -37.7 ± 13.6 | -222.2 ± 63.0 |
MERS: Entire virus | -63.8 ± 30.5 | 30.5 ± 6.0 | -24.3 ± 32.3 | -5.2 ± 60.1 | 7.7 ± 13.2 | -7.5 ± 64.0 |
MERS: Nucleocapsid | -73.9 ± 29.4 | 32.1 ± 6.3 | -32.3 ± 31.3 | -218.8 ± 59.0 | -34.8 ± 13.5 | -208.5 ± 63.0 |
SARS-1: Entire virus | -64.5 ± 30.5 | 30.7 ± 6.1 | -24.7 ± 32.3 | -4.5 ± 60.1 | 6.6 ± 13.2 | -6.5 ± 64.0 |
SARS-1: Nucleocapsid | -75.6 ± 29.4 | 32.5 ± 6.4 | -33.5 ± 31.3 | -242.0 ± 58.9 | -39.2 ± 13.6 | -230.3 ± 63.0 |
Lung - parenchyma | -65.6 ± 30.7 | 31.4 ± 6.2 | -24.9 ± 32.6 | -50.5 ± 60.3 | -2.8 ± 13.4 | -49.8 ± 64.3 |